{"schema_version":"1","generated_at":"2026-11-01T04:01:47.599Z","data_as_of":null,"url":"https://www.findmykol.com/kol/gregory-roloff","json_url":"https://www.findmykol.com/kol/gregory-roloff/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"gregory-roloff","name":"Gregory Roloff","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Chicago","institution_url":"https://www.findmykol.com/institution/university-of-chicago","city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1841795929","orcid":"0000-0003-2109-5152","openalex":"A5045161326"},"summary":"Gregory Roloff is an Oncology physician affiliated with University of Chicago. OpenAlex indexes 99 publications with 801 citations (h-index 15).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":99,"cited_by_count":801,"h_index":15,"latest_activity_year":2026,"emerging":true,"source":"works"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":10,"shown":3,"withheld":7,"rows":[{"payer":"Autolus Inc","program_year":2025,"amount_usd":10478.49,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841795929"},{"payer":"Kite Pharma, Inc.","program_year":2025,"amount_usd":8620.13,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841795929"},{"payer":"Rigel Pharmaceuticals, Inc.","program_year":2025,"amount_usd":3788.75,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841795929"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1841795929","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":38.6,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":38.6,"drugs":[{"name":"Calquence","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":34.1,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":34.1,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":27.3,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":27.3,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL","year":2026,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2025031734","status":"verified"},{"title":"Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024014846","status":"verified"},{"title":"Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024015779","status":"verified"},{"title":"CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025017526","status":"verified"},{"title":"Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-516","status":"verified"}],"source":"works"},"contact":{"address_1":"5841 S MARYLAND AVE # MC2115","city":"Chicago","state":"IL","zip":"606371443","phone":"773-702-2731","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1841795929","source":"identity"},"similar":[{"name":"Everett Vokes","slug":"everett-vokes","institution":"University of Chicago","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/everett-vokes","json_url":"https://www.findmykol.com/kol/everett-vokes/profile.json"},{"name":"Ralph Weichselbaum","slug":"ralph-weichselbaum","institution":"University of Chicago","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/ralph-weichselbaum","json_url":"https://www.findmykol.com/kol/ralph-weichselbaum/profile.json"},{"name":"Mary Rinella","slug":"mary-rinella","institution":"University of Chicago","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/mary-rinella","json_url":"https://www.findmykol.com/kol/mary-rinella/profile.json"},{"name":"Hedy Kindler","slug":"hedy-kindler","institution":"University of Chicago","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/hedy-kindler","json_url":"https://www.findmykol.com/kol/hedy-kindler/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":7,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-06-25","provider_certified":"2021-06-25","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}